Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia?

European Journal of Neurology

Volumn 15, Issue 3, 2008, Pages 262-267

  Lyros, E ^a   Messinis, L ^a   Papathanasopoulos, P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cognitive dysfunction; Gait; Instability; Motor subtype; Parkinson's disease

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; HUMAN; LEARNING; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PARKINSON DISEASE; PERFORMANCE; POSTURAL INSTABILITY AND GAIT DIFFICULTY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; STATISTICAL SIGNIFICANCE;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 39149144027     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.02046.x     Document Type: Article

References (36)

1. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990 40 : 1529 1534.
2. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 : 585 589.
3. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Movement Disorders 2006 21 : 1123 1130.
4. Emre M. What causes mental dysfunction in Parkinson's disease? Movement Disorders 2003 18 (Suppl. 6 S63 S71.
5. Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000 55 : 539 544.
6. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991 114 : 2095 2122.
7. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? Journal of Neurology, Neurosurgery and Psychiatry 1989 52 : 201 206.
8. Dubois B, Pilon B, Lhermitte F, Agid Y. Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Annals of Neurology 1990 28 : 117 121.
9. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2007 78 : 1182 1187.
10. Zakharov VV, Akhutina TV, Yakhno NN. Memory impairment in Parkinson's disease. Neuroscience and Behavioural Physiology 2001 31 : 157 163.
11. Green J, McDonald WM, Vitek JL, et al. Cognitive impairments in advanced PD without dementia. Neurology 2002 59 : 1320 1324.
12. Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005 65 : 1907 1913.
13. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005 65 : 1239 1245.
14. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1988 51 : 745 752.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967 17 : 427 442.
16. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In : Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson's Disease, Vol II. New Jersey : Macmillan Healthcare Information, 1987 153 163.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Text revision 4th edn. Washington, DC : APA, 2000.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975 12 : 189 198.
19. Beck AT, Steer RA, Brown GK. BDI-Fast Screen For Medical Patients: Manual. San Antonio, TX : Harcourt Assessment/The Psychological Corporation, 2000.
20. Messinis L, Tsakona I, Malefaki S, Papathanasopoulos P. Normative data and discriminant validity of Rey's auditory verbal learning test for the Greek adult population. Archives of Clinical Neuropsychology 2007 22 : 739 752.
21. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th edn. New York : Oxford University Press, 2004.
22. Vlahou CH, Kosmidis MH. The Greek trail making test: preliminary normative data for clinical and research use. The Journal of the Hellenic Psychological Society 2002 9 : 336 352.
23. Argirokastritou E, Samanda T, Messinis L. Preliminary Normative Data for the Symbol Digit Modalities Test (SDMT) in Greece. 10th Panhellenic Congress of Psychology, December 1-4, Ioannina, Greece, 2005.
24. Messinis L. Stroop neuropsychological screening test and repeatable battery for the assessment of neuropsychological status (RBANS) (translation and adaptation). In : Stalikas A, Triliva S, Roussi P, eds. Psychometric Tools in Greece, 2nd edn. Athens : Ellinika Grammata In Greek 2008 (In Press).
25. Perry EK, Morris CM, Court JA, et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 1995 64 : 385 395.
26. Fujita M, Ichise M, Zoghbi SS, et al. Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease. Annals of Neurology 2006 59 : 174 177.
27. Forgacs PB, Bodis-Wollner I. Nicotinic receptors and cognition in Parkinson's disease: the importance of neuronal synchrony. Journal of Neural Transmission 2004 111 : 1317 1331.
28. Cools R. Dopaminergic modulation of cognitive function implications for L-DOPA treatment in Parkinson's disease. Neuroscience and Biobehavioral Reviews 2006 30 : 1 23.
29. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000 123 : 1767 1783.
30. Inglis WL, Olmstead MC, Robbins TW. Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behavioural Brain Research 2001 123 : 117 131.
31. Dormont JF, Conde H, Farin D. The role of the pedunculopontine tegmental nucleus in relation to conditioned motor performance in the cat. I. Context-dependent and reinforcement-related single unit activity. Experimental Brain Research 1998 121 : 401 410.
32. Brooks DJ. Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms? Journal of Neural Transmission (Suppl.) 1999 56 : 139 153.
33. Parker F, Tzourio N, Blond S, Petit H, Mazoyer B. Evidence for a common network of brain structures involved in parkinsonian tremor and voluntary repetitive movement. Brain Research 1992 584 : 11 17.
34. Mentis MJ, McIntosh AR, Perrine K, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. American Journal of Psychiatry 2002 159 : 746 754.
35. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007 34 : 714 723.
36. Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 : 343 348.